{"id":"https://openalex.org/W4399090848","doi":"https://doi.org/10.1201/9781003526827-5","title":"The Role of the FDA in Drug Development in Inflammatory Bowel Disease","display_name":"The Role of the FDA in Drug Development in Inflammatory Bowel Disease","publication_year":2024,"publication_date":"2024-05-28","ids":{"openalex":"https://openalex.org/W4399090848","doi":"https://doi.org/10.1201/9781003526827-5"},"language":"en","primary_location":{"id":"doi:10.1201/9781003526827-5","doi":"https://doi.org/10.1201/9781003526827-5","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1201/9781003526827-5","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ulcerative Colitis","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4399090624","display_name":"Ulcerative Colitis"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062491410","display_name":"Alan C. Moss","orcid":"https://orcid.org/0000-0003-0179-5477","observed_orcids":["https://orcid.org/0000-0003-0179-5477","https://orcid.org/0009-0007-0879-3884"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan C. Moss","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060108766","display_name":"Adam S. Cheifetz","orcid":"https://orcid.org/0000-0002-6010-1896","observed_orcids":["https://orcid.org/0000-0002-6010-1896"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam S. Cheifetz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.27340067,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"33","last_page":"39"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9240000247955322},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6320000290870667},{"id":"https://openalex.org/keywords/food-and-drug-administration","display_name":"Food and Drug Administration","score":0.8550000190734863},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.890999972820282},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":1.0},{"id":"https://openalex.org/keywords/regulatory-approval","display_name":"regulatory approval","score":0.5460000038146973},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.8830000162124634},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.7149999737739563},{"id":"https://openalex.org/keywords/new-chemical-entities","display_name":"new chemical entities","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.8325789570808411},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.69178307056427},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5983880758285522},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5573329329490662},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.49542248249053955},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4298862814903259},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3216277062892914},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2988053858280182}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781003526827-5","doi":"https://doi.org/10.1201/9781003526827-5","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1201/9781003526827-5","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ulcerative Colitis","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2084432461","https://openalex.org/W3108065059","https://openalex.org/W2922022420","https://openalex.org/W2065386438","https://openalex.org/W4249662379","https://openalex.org/W3010700640","https://openalex.org/W4406968879","https://openalex.org/W4322775175","https://openalex.org/W4304757193","https://openalex.org/W2899426586"],"abstract_inverted_index":{"Inflammatory":[0],"bowel":[1],"disease":[2,161],"(IBD)":[3],"affects":[4],"approximately":[5],"1":[6,56],"million":[7,15],"individuals":[8],"in":[9,34,63,85,95,117,153,162],"the":[10,18,53,76,96,103,118,141,145,154,170,182],"United":[11,97,119],"States":[12],"and":[13,90,136,147],"4":[14],"people":[16],"worldwide,":[17],"majority":[19],"of":[20,29,39,131,149,160,175],"whom":[21],"are":[22,43,83],"prescribed":[23],"medication":[24],"for":[25,87,92,105,107,169],"induction":[26],"or":[27,158],"maintenance":[28],"remission.":[30],"At":[31],"any":[32],"point":[33],"time,":[35],"more":[36],"than":[37,52],"75%":[38],"patients":[40,109],"with":[41,128],"IBD":[42,108],"taking":[44],"prescription":[45],"medication,":[46],"which":[47],"is":[48,110,124,172],"3":[49,133],"times":[50],"higher":[51],"non-IBD":[54],"population.":[55],"In":[57,164],"addition":[58],"to":[59,75,114,126,143],"standard":[60],"therapies,":[61],"developments":[62],"molecular":[64],"biology":[65],"have":[66],"identified":[67],"many":[68],"novel":[69],"therapeutic":[70,177],"targets":[71],"that":[72,123],"will":[73],"add":[74],"patient's":[77],"options.":[78],"Currently,":[79],"24":[80],"new":[81,176],"drugs":[82,106,151],"registered":[84],"development":[86,184],"ulcerative":[88],"colitis":[89],"36":[91],"Crohn's":[93],"disease,":[94],"States.":[98],"2":[99],"As":[100],"a":[101,121,166],"consequence,":[102],"market":[104],"valued":[111],"at":[112],"$1":[113],"$2":[115],"billion":[116],"States,":[120],"number":[122],"expected":[125],"rise":[127],"increasing":[129],"use":[130],"biologies.":[132],"The":[134],"Food":[135],"Drug":[137],"Administration":[138],"(FDA)":[139],"has":[140],"responsibility":[142],"ensure":[144],"safety":[146],"efficacy":[148],"all":[150],"used":[152],"\u201ccure,":[155],"mitigation,":[156],"treatment,":[157],"prevention":[159],"man.\u201d":[163],"IBD,":[165],"major":[167],"role":[168],"FDA":[171],"its":[173],"assessment":[174],"agents":[178],"as":[179],"they":[180],"navigate":[181],"drug":[183],"pipeline.":[185]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2024-05-29T00:00:00"}